v3.25.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenues:        
Total revenues $ 8,601 $ 12,833 $ 31,472 $ 37,885
Costs and operating expenses:        
Cost of product revenue 2,465 4,317 7,295 12,634
Research and development 13,868 11,505 40,586 34,164
Selling, general and administrative 11,217 13,568 35,889 42,100
Asset impairment and other charges 0 0 0 165
Total costs and operating expenses 27,550 29,390 83,770 89,063
Loss from operations (18,949) (16,557) (52,298) (51,178)
Interest income 634 849 1,969 2,730
Interest and other expense, net (1,292) (4,922) (3,217) (6,421)
Loss before income taxes (19,607) (20,630) (53,546) (54,869)
Provision for income taxes 8 10 29 31
Net loss $ (19,615) $ (20,640) $ (53,575) $ (54,900)
Net loss per share, basic (in dollars per share) $ (0.22) $ (0.29) $ (0.62) $ (0.78)
Net loss per share, diluted (in dollars per share) $ (0.22) $ (0.29) $ (0.62) $ (0.78)
Weighted average common stock shares used in computing net loss per share, basic (in shares) 90,251 72,032 86,045 70,759
Weighted average common stock shares used in computing net loss per share, diluted (in shares) 90,251 72,032 86,045 70,759
Product revenue        
Revenues:        
Total revenues $ 6,807 $ 11,158 $ 20,246 $ 26,968
Research and development revenue        
Revenues:        
Total revenues $ 1,794 $ 1,675 $ 11,226 $ 10,917

Source